The aberrant SOX2 and LMX1A expression in human CP tumors suggests that SOX2-LMX1 signaling plays an important role in tumor development, and may serve as a therapeutic target.50 Consistently, our results demonstrated that inhibition of NOTCH signaling suppresses SOX2-LMX1 signaling in tumor cells. Here, LMX1A is linked to neoplasm.